Tnuki Research / Account Maps / Merck
Account Map — public preview
Merck account map & org chart
Where the work is, where it's growing, and who leads it — mapped from Merck's own public footprint: hiring activity, scientific literature, and professional profiles.
Merck·Key facts — organizational structure and hiring, August 2026
Merck here is Merck & Co., Inc. of Rahway, New Jersey — "Merck" in the United States and Canada, "MSD" everywhere else. Ten executives sit on the Executive Team with Chairman and CEO Robert M. Davis1. Dean Y. Li runs Merck Research Laboratories, the company's R&D organization. Dave Maraldo runs the Merck Manufacturing Division. Human-health commercial work is split in two: Jannie Oosthuizen leads Oncology and MSD International, and Brian Foard leads Specialty, Pharma & Infectious Diseases13. Richard R. DeLuca, Jr. runs Merck Animal Health, the company's second reporting segment.
- We found 551 Merck teams hiring in the past four quarters, and 9,292 leaders at Associate Director level or above. All of it from public sources.
- Cardiovascular Disease posts the most roles (134, a field organization posting across U.S. territories), then Vaccines (89, 3.6 times its prior window), Analytical R&D (61) and Technical Product Management (58). Clinical Research is growing fastest, from 5 roles to 36. Observed postings across the company grew 2.2 times window over window, so read every unit's multiple against that baseline.
- Most of the hiring is in the United States (2,539 location listings), then India (236) and Singapore (83). Rahway, the headquarters, is the busiest city with 656, followed by the Pennsylvania cluster of North Wales (324), Lansdale (163), Upper Gwynedd (162) and West Point (159).
- Merck reports its business in two operating segments: Pharmaceutical and Animal Health15.
Merck·How to read this map
What a "center of work" is
A named team, department, or group inside Merck — the level at which budgets are spent and vendors are chosen. Account-level views are too coarse for an organization of this size; this map operates one level down, at the unit where your buyer actually sits.
Highlights
Scope
The consolidated corporate group — Merck & Co., Inc. and its subsidiaries, including Merck Animal Health. Merck KGaA of Darmstadt, Germany is an unrelated company and is excluded from the corpus at pull time.
Where the data comes from
Hiring activity. Public job postings, including the hiring team named in each posting. The most current public signal of where a unit is investing.
Scientific literature. Author affiliations in peer-reviewed publications, which name R&D groups that rarely appear in any commercial channel. This map also summarizes what the most prolific centers publish on.
Professional profiles. Associate Director-and-above profiles, cross-checked for currency; every name in the full document carries a freshness flag.
What this map is not
A map of Merck's publicly visible organization. Units that neither hire publicly nor publish — manufacturing floor teams, some corporate functions — are under-represented.
Merck·Centers of work — ranked by hiring activity
The 30 most active units by open roles in the trailing four quarters, of 551 units with any hiring activity in the window (drawn from 5,259 verbatim-extracted unit-name candidates). Rows are centers of activity, not an org chart — several (therapeutic areas especially) sit inside larger divisions rather than beside them. = corroborated by 2+ independent sources.
Reading the momentum column
Momentum is the unit's own posting count, last four quarters vs the four before: ▲ 2.0× = twice as many postings. The arrow marks units moving well beyond (or against) the company-wide trend — observed Merck postings grew 2.2× window-over-window, so a unit can show a multiple above 1.0 with no arrow (it merely rode the surge) or a down-arrow at 1.5× (it lost share). Too little history shows "—" rather than a noisy number.
| Unit | Roles 4q | Momentum | Dir+ leaders | Top leader | Primary locations |
|---|---|---|---|---|---|
| Cardiovascular Disease A field organization: posting locations are sales territories rather than sites. | 134 | — | 0 | Zanesville, Columbia | |
| Vaccines | 89 | ▲ 3.6× | 43 | In the full map · VP | Ho Chi Minh City, Hanoi |
| Analytical R&Dwithin Merck Research Laboratories | 61 | 3.2× | 9 | In the full map · VP | Rahway, Lansdale |
| Technical Product Management | 58 | ▲ 5.3× | 40 | In the full map · Exec Director | Hyderabad, Rahway |
| Clinical Researchwithin Merck Research Laboratories Organized by therapeutic area under Vice President-level Therapeutic Area Heads; the deepest leadership bench in the map. | 36 | ▲ 7.2× | 210 | In the full map · VP | Rahway, Boston |
| Virology (HIV) | 33 | — | 2 | In the full map · Director | Fort Worth, San Antonio |
| Software Engineering | 32 | ▼ 1.5× | 15 | In the full map · Director | Hyderabad, Rahway |
| Statistical Programming | 26 | 3.2× | 20 | In the full map · Exec Director | North Wales, Rahway |
| Learning & Development | 25 | ▲ 4.2× | 47 | In the full map · Exec Director | Mumbai, North Wales |
| Clinical Data Management | 20 | — | 73 | In the full map · Exec Director | West Point, Rahway |
| Outcomes Researchmedical organization | 19 | ▲ 4.8× | 69 | In the full map · Assoc VP | Rahway, North Wales |
| Cybersecurity Engineering | 19 | 1.9× | 1 | In the full map · Assoc Director | Hyderabad, Rahway |
| Manufacturing Automation | 18 | ▼ 0.9× | 14 | In the full map · Assoc Director | Pune, Lansdale |
| BiostatisticsR&D | 16 | 2.7× | 13 | In the full map · VP | North Wales, Rahway |
| Quantitative Pharmacology and Pharmacometrics (QP2) | 14 | 2.8× | 25 | In the full map · Assoc VP | Rahway, West Point |
| Safety & Environment | 14 | — | 24 | West Point, Dunboyne | |
| Chronic Care | 14 | ▲ 4.7× | 2 | Charleston, San Jose | |
| Drug Safety | 14 | — | 24 | Bogotá, Ciudad de México | |
| Infrastructure Engineering | 14 | — | 3 | In the full map · Director | Hyderabad, Rahway |
| Biologics Analytical Research & Development | 13 | 3.2× | 6 | In the full map · Exec Director | Rahway |
| Project Management | 13 | ▲ 4.3× | 102 | In the full map · Exec Director | North Wales, Mexico City |
| Discovery Oncology | 13 | 2.6× | 5 | In the full map · Exec Director | South San Francisco, Boston |
| Pharmacokinetics | 13 | — | 2 | In the full map · Assoc VP | South San Francisco, Lansdale |
| Global Communications | 12 | — | 31 | Rahway, North Wales | |
| RuminantsMerck Animal Health | 12 | — | 0 | Pune, Raigarh | |
| Immunology - GI | 12 | 1.5× | 1 | In the full map · Director | North Wales, New City |
| Regulatory CMC | 11 | 1.8× | 57 | Hyderabad, Rahway | |
| Health Systems | 11 | — | 21 | In the full map · Exec Director | North Wales, Houston |
| Pharmaceutical Analytical Sciences | 11 | — | 2 | In the full map · Director | Rahway |
| Oral Formulation Sciences | 10 | ▼ 1.1× | 3 | In the full map · Exec Director | Rahway |
Merck·Hiring momentum — where posting activity is shifting
How to use this page. A unit gaining hiring share is standing up capacity — the best moment to engage is while teams and tooling are still being chosen. A unit losing share may be post-reorg, outsourcing, or completing a build-out; treat the flag as a prompt to ask, not a conclusion.
Gaining share
Losing share — verify before investing effort
Merck·Global footprint — where the hiring lands
Posting locations for the trailing four quarters of hiring, aggregated across all mapped units. Counts are location listings — a posting advertised in several locations counts once per location, so totals exceed distinct postings. Use this to route territory and plan on-site coverage.
Top 12 countries
Most active cities
Merck·Leadership by center of work — who to call
Named Associate Director+ leadership for the busiest centers of work. Every row is flagged for currency: verified = confirmed as current during this snapshot's verification pass (a web check, an active-position signal, or the company's own page); verify = sourced but not recently re-confirmed — check before outreach. In this public edition, a lock marks a leader named in the full map.
Clinical Research
| VP | In the full map | Vice President & Therapeutic Area Head, Clinical Research — Immunology | verified |
| VP | In the full map | Vice President and Therapeutic Area Head, Clinical Research — Infectious Diseases | verified |
| VP | In the full map | Vice President and Therapeutic Area Head, Vaccines Clinical Research | verified |
| Assoc VP | In the full map | Scientific Associate Vice President, Section Head, Early Oncology Clinical Research | verified |
| Assoc VP | In the full map | Associate Vice President, Vaccine Clinical Research | verified |
| Assoc VP | In the full map | Associate Vice President, Clinical Research — Head of Translational Pharmacology | verified |
Project Management
| R&D side | |||
| Exec Director | In the full map | Executive Director, CMC Integrated Project Management | verified |
| Exec Director | In the full map | Executive Director, Global Project Management | verified |
| Commercial side | |||
| Exec Director | In the full map | Executive Director, Project Management, Network Strategy & Third Party Sales | verified |
| Side not determinable from title | |||
| Sr Director | In the full map | Senior Director, Planning and Project Management | verified |
| Sr Director | In the full map | Senior Director, Project Management | verified |
| Director | In the full map | Director, Project Management | verified |
Global Medical Affairs
| Assoc VP | In the full map | Associate Vice President, Immunology Global Medical Affairs | verified |
| Exec Director | In the full map | Executive Director, Global Medical Affairs, Oncology Lead Asia Pacific | verified |
| Exec Director | In the full map | Executive Director, New Products | verified |
| Exec Director | In the full map | Executive Director, Global Medical Affairs — Global Expert Input & Medical Education | verified |
| Exec Director | In the full map | Executive Director, Medical Affairs — Global Medical and Value Capabilities, LATAM | verified |
| Exec Director | In the full map | Medical Affairs Fellowship Lead | verified |
Clinical Data Management
| Exec Director | In the full map | Executive Director, Clinical Data Management, Regional Head — LATAM | verified |
| Sr Director | In the full map | Senior Director, Clinical Data Management | verified |
| Director | In the full map | Director, Clinical Data Management | verified |
| Director | In the full map | Director, Clinical Data Management | verified |
| Director | In the full map | Director, Clinical Data Management | verified |
| Director | In the full map | Director, Clinical Data Management | verified |
Outcomes Research
| R&D side | |||
| Exec Director | In the full map | Regional Executive Director, Outcomes Research | verified |
| Medical | |||
| Assoc VP | In the full map | Associate Vice President, Outcomes Research | verified |
| Exec Director | In the full map | Executive Director, Outcomes Research | verified |
| Exec Director | In the full map | Executive Director, Outcomes Research | verified |
| Exec Director | In the full map | Executive Director, Outcomes Research, HIV / Infectious Diseases | verified |
| Exec Director | In the full map | Executive Director, Outcomes Research | verified |
Regulatory CMC
| Assoc VP | In the full map | Associate Vice President, Head of Regulatory CMC — Vaccines | verified |
| Assoc VP | In the full map | Associate Vice President, Global Regulatory Affairs — CMC | verified |
| Chief of Staff | In the full map | Chief of Staff, Global Regulatory Affairs CMC | verified |
| Exec Director | In the full map | Executive Director, CMC Regulatory | verified |
| Exec Director | In the full map | Executive Director and Team Lead, Post-Approval Regulatory CMC | verified |
| Exec Director | In the full map | Executive Director, Head of Regulatory CMC LATAM | verified |
Learning & Development
| Exec Director | In the full map | Executive Director, Human Resources Learning & Development | verified |
| Director | In the full map | Director of Learning and Development | verified |
| Director | In the full map | Director of Learning and Development | verified |
| Director | In the full map | Director, Learning & Development | verified |
| Director | In the full map | Director, Learning and Development | verified |
| Director | In the full map | Director of Learning and Development | verified |
Vaccines
| R&D side | |||
| Exec Director | In the full map | Executive Director, PDMB Regulated BioAnalytics, Vaccines | verified |
| Exec Director | In the full map | Executive Director, Vaccines Unit Lead | verified |
| Sr Director | In the full map | Senior Director, Regulatory Affairs — Regional Liaison LatAm, Vaccines | verified |
| Medical | |||
| VP | In the full map | Vice President, Vaccines, Value and Implementation, Outcomes Research | verified |
| Sr Director | In the full map | Senior Director, Center for Observational and Real-world Evidence, Vaccines | verified |
| Commercial side | |||
| Sr Director | In the full map | Senior Director, Payor & Access Strategy Team Lead — General Medicine and ID / Vaccines | verified |
Global Oncology Marketing
| VP | In the full map | Vice President, Global Oncology Marketing | verified |
| Assoc VP | In the full map | Associate Vice President, Global Oncology Marketing, Strategy & Operations | verified |
| Assoc VP | In the full map | Associate Vice President, Global Oncology Marketing | verified |
| Exec Director | In the full map | Executive Director, Global Oncology Marketing | verified |
| Exec Director | In the full map | Executive Director, Global Oncology Marketing | verified |
| Exec Director | In the full map | Executive Director, Global Oncology Marketing, Precision Medicine | verified |
Get the full map, with names, groups, and profile links. Leave your work email and we’ll be in touch.
Merck·Published research — which centers publish, and on what
Centers whose own staff lead-author peer-reviewed papers, from author affiliations in the scientific literature (2023–2026). Papers attach to a center only when the paper's affiliation names it exactly, so counts are lead-authored published evidence, not a census; 75 mapped centers carry publications in total. Several of these centers barely hire publicly — the literature is the only channel that surfaces them.
| Center | Lead papers | Dir+ leaders | What they publish on |
|---|---|---|---|
| Merck Research Laboratories (papers affiliated to MRL as a whole) | 196 | 20 | HIV-1 antivirals and reverse-transcriptase inhibitors, pneumococcal vaccine science, triple-negative breast cancer, cytomegalovirus; 52 clinical and 16 methods papers. |
| Analytical R&D | 141 | 9 | Analytical and bioanalytical methods for vaccines and biologics — RSV and COVID-19 analytics, NMR and solid-state NMR, hydrogen–deuterium exchange, Raman process analytics, polysorbate quantification; 61 open roles. |
| Center for Observational and Real-World Evidence (CORE) | 101 | 4 | Real-world evidence — pneumococcal pneumonia and all-cause pneumonia burden, HIV, COVID-19, chronic cough, small-cell lung cancer treatment patterns; claims-database methods. |
| Biostatistics and Research Decision Sciences (BARDS) | 84 | 3 | Biostatistics and decision science — pneumococcal-vaccine economics, Alzheimer's, missing-data and Bayesian trial methods, patient-reported outcome measurement. |
| Process Research & Development (PR&D) | 70 | — | Process chemistry and bioprocess — continuous countercurrent dialysis, CHO metabolic-flux analysis, nucleoside synthesis, high-throughput experimentation, Raman hyperspectral imaging. |
| Value & Implementation Outcomes Research (VIOR) | 50 | 8 | Value and outcomes research — pneumococcal disease, varicella, HPV, RSV hospitalization burden, COVID-19 quality of life, caregiver burden; social-vulnerability and comorbidity indices. |
| Global Animal Health R&D | 36 | 1 | Veterinary vaccines and parasiticides — African swine fever, canine influenza, Bordetella, Lawsonia; livestock and companion-animal field studies (Merck Animal Health). |
| Pharmaceutical Operations and Clinical Supply | 27 | 2 | Formulation and device science — subcutaneous bioavailability models, peptide aggregation, fill-volume simulation, needle-shield zinc migration; solid-state NMR and micro-flow imaging. |
| Biologics Process Research & Development | 24 | 4 | CHO cell-culture process — metabolic-flux rewiring, host-cell-protein reduction, antibody-reduction control, Southern-blot transgene detection; 9 open roles. |
The full map lists each center's papers, the diseases, targets, techniques, and instruments they name, and which leaders close the author list on the center's own work — independent corroboration that they run the group.
Merck·Org chart — how Merck's executive leadership is organized
Merck's stated leadership structure, drawn as reported: the Executive Team as the company lists it1, with each executive's organization taken from their own profile page, the 2025 operating- structure announcement, or the careers site. Every numbered superscript links to its source. A blue count on a card marks an organization whose internal structure is mapped in the following sections: official sub-organizations as boxes, observed teams as ◦ chips. Merck reports two operating segments — Pharmaceutical and Animal Health15 — and the Animal Health card is the whole of the second one.
Reading order for the next two sections: Merck Research Laboratories first — the largest mapped organization — then the Manufacturing Division, Animal Health, and the two human-health commercial organizations. The two commercial presidents are drawn as single boxes: Merck publishes their scope but not their internal structure, and the commercial-side centers appear in the leadership tables above.
Merck·Inside Merck Research Laboratories — organizational structure and observed teams
Boxes are official organizations as Merck describes them on its careers site17 — recruiting copy rather than a governance source, so treat the boxes as the company's own description of how MRL is arranged, not a reporting chart. Muted chips marked ◦ are teams observed in Merck's hiring activity and scientific literature (the mined corpus behind the rest of this map), attached beneath the official unit they sit in; a gray "5 roles·4q" means 5 open roles observed for that team in the trailing four quarters.
Merck·Inside the Manufacturing Division, Animal Health, and the commercial organizations
The Merck Manufacturing Division and Merck Animal Health mapped the same way — official cited boxes, observed ◦ chips — with the two human-health commercial organizations and Merck's reporting segments below.
Human-health commercial organizations
Merck restructured its human-health operating model in 2025 into two commercial organizations plus an enterprise access-and-policy function13. Merck publishes their scope, not their internal structure; the commercial-side centers in the tables above sit here.
Operating segments — how Merck reports its business
A financial-reporting grouping from the 10-K15, not a management chain.
Merck·Frequently asked questions
Is this Merck the same company as MSD?
Yes. This page covers Merck & Co., Inc., headquartered in Rahway, New Jersey. It trades as "Merck" in the United States and Canada and as "MSD" everywhere else. It is not Merck KGaA, the Darmstadt, Germany company, which is a separate business; nothing from Merck KGaA is in this map.
How is Merck organized in 2026?
Ten executives sit on the Executive Team with Chairman and CEO Robert M. Davis1. Dean Y. Li runs Merck Research Laboratories, Dave Maraldo runs the Manufacturing Division, and Richard R. DeLuca, Jr. runs Merck Animal Health. Human-health commercial work is split between Jannie Oosthuizen (Oncology and MSD International) and Brian Foard (Specialty, Pharma & Infectious Diseases). The corporate functions are finance (Caroline Litchfield), legal (Jennifer Zachary), human resources (Betty Larson), strategic access, policy and communications (Chirfi Guindo), and information and digital (Gaurav Gupta). Merck reports two segments: Pharmaceutical and Animal Health.
Who leads Merck's research and development?
Dean Y. Li, Executive Vice President and President of Merck Research Laboratories, the organization that covers discovery through late-stage development, regulatory affairs, clinical trial operations, and pharmaceutical sciences. A Senior Vice President inside MRL heads global clinical development and serves as Chief Medical Officer.
Which Merck units are hiring the fastest in 2026?
Compared with the four quarters before, Clinical Research grew 7.2 times (5 roles to 36), Technical Product Management 5.3 times (11 to 58), Outcomes Research 4.8 times (4 to 19), Chronic Care 4.7 times (3 to 14), Project Management 4.3 times (3 to 13), Learning & Development 4.2 times (6 to 25), and Vaccines 3.6 times (25 to 89). Observed postings across the company grew 2.2 times, so all seven are growing faster than Merck as a whole. By volume, Cardiovascular Disease posts the most roles (134), then Vaccines (89) and Analytical R&D (61).
Where is Merck hiring?
Mostly in the United States, which accounts for 2,539 location listings. The busiest cities are Rahway (656), North Wales (324), Lansdale (163), Upper Gwynedd Township (162), and West Point (159). Outside the U.S., India has the most (236 listings, mainly Hyderabad and Pune), then Singapore (83) and Japan (48).
What is an account map?
A view of a large company one level below the org chart: the named teams and departments where budgets get spent and vendors get chosen. We rank them by hiring activity and show who leads them, using only what the company makes public. That means job postings, scientific papers, leadership pages, and SEC filings. This page is the redacted version; the full PDF names every leader we identified.
Get the full map, with names, groups, and profile links. Leave your work email and we’ll be in touch.
More account maps in this series
Method & sources. Built exclusively from public sources: Merck's own job postings and careers system, author affiliations in peer-reviewed scientific literature, company leadership pages, SEC filings, press releases, and professional profiles. Numbered superscripts link to the company or SEC source for each cited fact. This is a redacted public edition: individual names appear only where Merck publishes them itself; photos and personal profile links are omitted. Roles and structures change — verify before outreach. Corrections or removal requests: support@tnuki.com.